Advertisement
KELYB vs TBI
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KELYB is a Hold and TBI is a StrongBuy.
KELYB in upward trend: 10-day moving average broke above 50-day moving average on October 22, 2026
The 10-day moving average for KELYB crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 87%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
KELYB moved above its 50-day moving average on October 19, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +8.69% 3-day Advance, the price is estimated to grow further. Considering data from situations where KELYB advanced for three days, in 46 of 65 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
KELYB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The 10-day RSI Indicator for KELYB moved out of overbought territory on November 02, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In 25 of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at 76%.
The Momentum Indicator moved below the 0 level on November 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on KELYB as a result. In 45 of 72 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 62%.
The Moving Average Convergence Divergence Histogram (MACD) for KELYB turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 29 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 69%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where KELYB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
The Aroon Indicator for KELYB entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.931) is normal, around the industry mean (4.795). P/E Ratio (-3.387) is within average values for comparable stocks, (1.381). Projected Growth (PEG Ratio) (0.929) is also within normal values, averaging (1.448). Dividend Yield (0.011) settles around the average of (1.499) among similar stocks. P/S Ratio (0.191) is also within normal values, averaging (0.884).
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. KELYB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 59 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 81 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KELYB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock better than average.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
TBI in +28.88% Uptrend, advancing for three consecutive days on November 05, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where TBI advanced for three days, in 198 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 23, 2026. You may want to consider a long position or call options on TBI as a result. In 51 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 61%.
The Moving Average Convergence Divergence (MACD) for TBI just turned positive on October 23, 2026. Looking at past instances where TBI's MACD turned positive, the stock continued to rise in 31 of 46 cases over the following month. The odds of a continued upward trend are 67%.
TBI moved above its 50-day moving average on October 26, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for TBI crossed bullishly above the 50-day moving average on November 03, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 47%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TBI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
TBI broke above its upper Bollinger Band on November 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for TBI entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.452) is normal, around the industry mean (4.795). P/E Ratio (-6.463) is within average values for comparable stocks, (1.381). Projected Growth (PEG Ratio) (0.782) is also within normal values, averaging (1.448). Dividend Yield (0.000) settles around the average of (1.499) among similar stocks. P/S Ratio (0.161) is also within normal values, averaging (0.884).
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. TBI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 87 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TBI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.
KELYB | TBI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 96 | 43 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 30 Undervalued | 27 Undervalued | |
PROFIT vs RISK RATING 1..100 | 81 | 100 | |
SMR RATING 1..100 | 96 | 95 | |
PRICE GROWTH RATING 1..100 | 36 | 34 | |
P/E GROWTH RATING 1..100 | 59 | 87 | |
SEASONALITY SCORE 1..100 | 50 | 65 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TBI's Valuation (27) in the Personnel Services industry is in the same range as KELYB (30). This means that TBI’s stock grew similarly to KELYB’s over the last 12 months.
KELYB's Profit vs Risk Rating (81) in the Personnel Services industry is in the same range as TBI (100). This means that KELYB’s stock grew similarly to TBI’s over the last 12 months.
TBI's SMR Rating (95) in the Personnel Services industry is in the same range as KELYB (96). This means that TBI’s stock grew similarly to KELYB’s over the last 12 months.
TBI's Price Growth Rating (34) in the Personnel Services industry is in the same range as KELYB (36). This means that TBI’s stock grew similarly to KELYB’s over the last 12 months.
KELYB's P/E Growth Rating (59) in the Personnel Services industry is in the same range as TBI (87). This means that KELYB’s stock grew similarly to TBI’s over the last 12 months.
| KELYB | TBI | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 76% | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 69% | 2 days ago 88% |
| Momentum ODDS (%) | 2 days ago 63% | 2 days ago 61% |
| MACD ODDS (%) | 2 days ago 69% | 2 days ago 67% |
| TrendWeek ODDS (%) | 2 days ago 61% | 2 days ago 69% |
| TrendMonth ODDS (%) | 2 days ago 62% | 2 days ago 64% |
| Advances ODDS (%) | 16 days ago 71% | 7 days ago 72% |
| Declines ODDS (%) | 8 days ago 74% | 24 days ago 80% |
| BollingerBands ODDS (%) | 2 days ago 63% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 60% | 2 days ago 89% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
KELYB’s FA Score shows that 1 FA rating(s) are green while TBI’s FA Score has 1 green FA rating(s).
- KELYB’s FA Score: 1 green, 4 red.
- TBI’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
KELYB’s TA Score shows that 5 TA indicator(s) are bullish while TBI’s TA Score has 5 bullish TA indicator(s).
- KELYB’s TA Score: 5 bullish, 5 bearish.
- TBI’s TA Score: 5 bullish, 5 bearish.
Price Growth
KELYB (@Other Consumer Services) experienced а -10.00% price change this week, while TBI (@Other Consumer Services) price change was +32.22% for the same time period.
The average weekly price growth across all stocks in the @Other Consumer Services industry was +184.51%. For the same industry, the average monthly price growth was +167.45%, and the average quarterly price growth was +174.88%.
Reported Earning Dates
KELYB is expected to report earnings on Feb 18, 2027.
TBI is expected to report earnings on Feb 03, 2027.
Industries' Descriptions
@Other Consumer Services (+184.51% weekly)Other consumer services include companies that provide consumer services, and are not classified elsewhere. Travel fare aggregators, hotel bookings, consumer-to-consumer or business-to-business sales platforms are some examples of services that can be clubbed into this category. Many of such services have expanded online. Booking Holdings Inc, The Priceline Group Inc, and eBay Inc. are some major operators in this segment.
Advertisement
KELYB and
Correlation & Price change
A.I.dvisor tells us that KELYB and KELYA have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KELYB and KELYA's prices will move in lockstep.
| Ticker / NAME | Correlation To KELYB | 1D Price Change % | ||
|---|---|---|---|---|
| KELYB | 100% | +0.37% | ||
| KELYA - KELYB | 22% Poorly correlated | +3.08% | ||
| JOB - KELYB | 22% Poorly correlated | -2.51% | ||
| PAYX - KELYB | 21% Poorly correlated | +1.25% | ||
| ZIP - KELYB | 17% Poorly correlated | +53.61% | ||
| TBI - KELYB | 4% Poorly correlated | +4.36% | ||
More | ||||
TBI and
Correlation & Price change
A.I.dvisor tells us that TBI and ZIP have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TBI and ZIP's prices will move in lockstep.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| NVDQ | 13.91 | 1.37 | +10.93% |
| T-Rex 2X Inverse NVIDIA Daily Target ETF (NVDQ) | |||
| DSPY | 65.73 | -0.14 | -0.22% |
| Tema S&P 500 Historical Weight ETF | |||
| GTR | 27.06 | -0.12 | -0.43% |
| WisdomTree Target Range Fund (GTR) | |||
| VTG | 73.20 | -0.44 | -0.60% |
| Vanguard Total Treasury ETF (VTG) | |||
| JASMY.X | 0.003666 | -0.000083 | -2.21% |
| JasmyCoin cryptocurrency | |||